Tick-borne encephalitis medical therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ilan Dock, B.S.
|
Tick-borne encephalitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tick-borne encephalitis medical therapy On the Web |
|
American Roentgen Ray Society Images of Tick-borne encephalitis medical therapy |
|
Risk calculators and risk factors for Tick-borne encephalitis medical therapy |
Overview
Medical Therapy
There are four main catgeories of treatment for Tick-borne encephalitis:
- Phosphrenyl, both a therapeutic and prophylactic agent for TBEinterferon treatment (like interferon for Hepatitis C)antibiotic treatment for possible tickborne co-infections phytotherapy.[1][2][3]
Antibiotics
- Although the TBE virus cannot be eradicated from the body, it can be inactivated. It can also be activated.[4]
- Certain antibiotics activate the TBE virus while others have no effect.
- TBE virus may be a coinfection with a Borrelia Burgdorferi infection, Lyme disease, which needs treatment with antibiotics.
- The Russians studied this matter for years and their findings were as follows: gentamicin exerts no activating effect while streptomycin and ten other antibiotics activate the virus. [5]
- They also found that some herbs inactivated the TBE virus almost completely in mice, as follows: ledum, motherwort and blackcurrant.[6][7]
References
- ↑ Streptomycin--an activator of persisting tick-borne encephalitis virus.Malenko G, Pogodina V, Karmysheva V (1984). "[Streptomycin--an activator of persisting tick-borne encephalitis virus]". Vopr Virusol. 29 (2): 217–23. PMID 6730440. Unknown parameter
|month=ignored (help) - ↑ Experimental phytotherapy of tick-borne encephalitis.Fokina G, Frolova T, Roĭkhel' V, Pogodina V (1991). "[Experimental phytotherapy of tick-borne encephalitis]". Vopr Virusol. 36 (1): 18–21. PMID 1858353. Unknown parameter
|month=ignored (help) - ↑ Protective effect of a new antiviral preparation of phosprenyl in experimental tick-borne encephalitis.Ozherelkov S, Timofeev A, Novikova G, Deeva A, Narovlianskiĭ A, Sanin A, Pronin A (2000). "[Protective effect of a new antiviral preparation of phosprenyl in experimental tick-borne encephalitis]". Vopr Virusol. 45 (1): 33–7. PMID 10695042. Unknown parameter
|month=ignored (help) - ↑ The search for antibiotics not exerting activating action in the persistence of the tick-borne encephalitis virus. Malenko G, Pogodina V (. 1989). "[The search for antibiotics not exerting activating action in the persistence of the tick-borne encephalitis virus]". Vopr Virusol. 34 (2): 197–200. PMID 2788330. Unknown parameter
|month=ignored (help); Check date values in:|year=(help) - ↑ Effect of gentamycin on persistence of tick-borne encephalitis.Pogodina V, Malenko G, Karmysheva V, Frolova M (1999). "[Effect of gentamycin on persistence of tick-borne encephalitis]". Vopr Virusol. 44 (1): 35–9. PMID 10190241. Unknown parameter
|month=ignored (help) - ↑ Strategy for choosing antibiotics for treating bacterial infections associated with chronic tick-borne encephalitis.Malenko G, Pogodina V, Frolova M, Ivannikova T (1996). "[Strategy for choosing antibiotics for treating bacterial infections associated with chronic tick-borne encephalitis]". Vopr Virusol. 41 (3): 138–41. PMID 8928510. Unknown parameter
|month=ignored (help) - ↑ The efficacy of lincomycin in tick-borne encephalitis.Votiakov V, Mishaeva N, Protas I, Ierusalimskiĭ A, Shutov A, Kovalenko V, Kichkil'deev N, Samoĭlova T, Drakina S, Zgirovskaia A (1992). "[The efficacy of lincomycin in tick-borne encephalitis]". Klin Med (Mosk). 70 (1): 65–7. PMID 1608216.